Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease

A Prospective, Open Label, One-arm, 4-weeks Study Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease -Phase 1 Study in Dry Eye Patients

The objective of this study is to assess safety and efficacy of DE-089 ophthalmic solution in patients with dry eye disease in Taiwan.

Inclusion Criteria:

• At least 6-month dry eye history

Exclusion Criteria:

• Diagnosed with Stevens-Johnson Syndrome or ocular pemphigoid
• Diagnosed with keratoconjunctival chemical burns or thermal burn
• Eye disease other than dry eye disease which needs treatment
• Allergic conjunctivitis that may possibly be aggravated during the clinical study and inappropriate for efficacy evaluation
• Those who need to wear contact lenses during the clinical study
• Those who are considered inappropriate for this study by the investigator or subinvestigators